RECRUITING

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

Description

The study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.

Conditions

Small Lymphocytic Lymphoma (SLL)Chronic Lymphocytic Leukemia (CLL)
Talk to us

Related Conditions:

Small Lymphocytic Lymphoma (SLL)Chronic Lymphocytic Leukemia (CLL)

Study Overview

On this page

Study Details

Study overview

The study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.

Predictors of Health-Related Quality of Life in Adults With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

Condition
Small Lymphocytic Lymphoma (SLL)
Intervention / Treatment

-

Contacts and Locations

Tampa

Moffitt Cancer Center, Tampa, Florida, United States, 33612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All patients with pathology-confirmed diagnoses of CLL who are within seven days of starting treatment with a BTKi +/- an anti-CD 20 monoclonal antibody or BCL2i with Obinutuzumab treatment will be included.
  • * Subjects must be able to read and speak English or Spanish at the 8th grade level.
  • * Patients with dementia, traumatic brain injury, or individuals with central nervous system involvement of their leukemia will be excluded from study participation.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

H. Lee Moffitt Cancer Center and Research Institute,

Sara Tinsley-Vance, PhD, APRN, AOCN, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

2028-06